Female | 28 (88) |
Age at presentation, yrs | 42.3 ± 17.6 (40.1) |
Disease duration at first episode, yrs | 9.7 ± 9.0 (7.9 ) |
Age at SLE diagnosis, yrs | 32.6 ± 17.5 (27.6) |
Mean length of followup, yrs | 9.0 ± 10.9 (4.4) |
Interval between the 2 consecutive visits | |
with hematuria | 4.3 ± 1.7 (3.4) |
Duration of hematuria and/or pyuria (mos) | 8.0 ± 7.2 (5.9) |
Race | |
White | 18 (56) |
Black | 5 (16) |
Asian | 4 (13) |
Others | 5 (16) |
Treatment at presentation | |
Prednisone | 23 (72) |
Antimalarial | 18 (56) |
Immunosuppressants | 14 (44) |
SLE: systemic lupus erythematosus.